|
|
| | CZC-25146 hydrochloride Basic information |
| Product Name: | CZC-25146 hydrochloride | | Synonyms: | CZC-25146 hydrochloride;CZC-25146.HCl;CZC-25146.HCL;N-[2-[[5-FLUORO-2-[[2-METHOXY-4-(4-MORPHOLINYL)PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]PHENYL]-METHANESULFONAMIDE HYDROCHLORIDE;N-[2-[[5-Fluoro-2-[[2-Methoxy-4-(4-Morpholinyl)phenyl]aMino]-4-pyriMidinyl]aMino]phenyl]-MethanesulfonaMide hydrochloride;CS-1206;CS-1074;CZC-25146; CZC 25146; CZC25146;CZC25146 HYDROCHLORIDE;CZC 25146 HYDROCHLORIDE;CZC-25146 hydrochL | | CAS: | 1330003-04-7 | | MF: | C22H26ClFN6O4S | | MW: | 524.9960432 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 1330003-04-7.mol |  |
| | CZC-25146 hydrochloride Chemical Properties |
| storage temp. | 2-8°C | | solubility | DMSO: >15mg/mL (warmed) | | form | powder | | color | white to beige |
| Hazard Codes | T,Xi | | Risk Statements | 25-36 | | Safety Statements | 26-45 | | RIDADR | UN 2811 6.1 / PGIII | | WGK Germany | 3 |
| | CZC-25146 hydrochloride Usage And Synthesis |
| Uses | N-(2-(2-(2-Methoxy-4-morpholinophenylamino)-5-fluoropyrimidin-4-ylamino)phenyl)methanesulfonamide is a compound that acts as an inhibitor of LRRK2, a factor in the expression of Parkinsons’s disease, and is ATP-competitive. |
| | CZC-25146 hydrochloride Preparation Products And Raw materials |
|